The second trimester is often described as the most comfortable phase of pregnancy — morning sickness has typically eased for many women, energy levels tend to improve, and the visible signs of pregnancy begin to emerge. But for women who conceived after 35, the second trimester also brings a distinctive set of prenatal screenings that can feel both reassuring and anxiety-inducing. Understanding what these tests involve, what they’re looking for, and how to think about the results may help make this period feel a little more navigable.
Prenatal screening recommendations have evolved considerably over the past two decades, and the landscape can look quite different depending on when you last engaged with this information. The good news is that the second trimester now offers a range of screening and diagnostic options that provide more information than ever before — while also raising questions about how to interpret and act on that information. Working closely with your OB/GYN or maternal-fetal medicine specialist is the most important step in this process.
It’s also worth noting that not every woman will need the same tests, and not every abnormal screening result will indicate a problem. Screening tests are designed to identify pregnancies that may benefit from further evaluation — they are not diagnoses. This distinction is worth keeping in mind as you navigate what can be a complex and emotionally charged part of pregnancy care.
The Anatomy Ultrasound: A Detailed Look at Fetal Development
The anatomy scan, typically performed between 18 and 22 weeks of pregnancy, is one of the most comprehensive prenatal assessments available in the second trimester. During this ultrasound, a sonographer systematically examines the fetal brain, heart, spine, kidneys, limbs, face, and other structures to check for anatomical variations that might warrant further evaluation. The placenta’s position and amniotic fluid levels are also assessed.
According to the American College of Obstetricians and Gynecologists, the anatomy scan is a routine part of prenatal care and is recommended for all pregnancies. For women over 35, this scan takes on particular significance as part of a broader picture of pregnancy monitoring. Most anatomy scans are reassuring, though some findings may prompt additional imaging or referral to a specialist. If your provider recommends follow-up, it’s worth asking what specifically they are evaluating further and what the possible interpretations might be.
What the Anatomy Scan Can and Cannot Detect
While the anatomy scan is thorough, it is not a complete guarantee that all structural issues will be identified. Detection rates vary depending on fetal position, maternal body habitus, the quality of the equipment, and the expertise of the sonographer. Some conditions are not visible until later in pregnancy or after birth. Understanding these limitations helps frame the scan as a valuable but imperfect tool rather than a definitive clearance.
Maternal Serum Screening: The Quad Screen and Beyond
The quad screen is a blood test typically offered between 15 and 20 weeks of pregnancy that measures four substances — AFP (alpha-fetoprotein), hCG (human chorionic gonadotropin), estriol, and inhibin A — to estimate the risk of certain chromosomal conditions, including Down syndrome (trisomy 21), trisomy 18, and neural tube defects. Results are expressed as risk ratios, not certainties, and are calculated in the context of your age, weight, gestational age, and other factors.
For women over 35, the baseline risk of chromosomal differences increases with age, which means that the quad screen results are always interpreted within your age-related risk profile. A “screen positive” result does not mean your baby has a chromosomal condition — it means the calculated risk falls above a certain threshold and further evaluation, such as amniocentesis, may be offered. Conversely, a “screen negative” result significantly lowers — but does not eliminate — the likelihood of those conditions. Many women who are navigating prenatal care after 35 choose to layer multiple screening approaches to gather the most complete picture possible.
Cell-Free DNA Screening (NIPT) in the Second Trimester
Non-invasive prenatal testing (NIPT), which analyzes fragments of fetal DNA circulating in maternal blood, is most commonly performed in the first trimester but can also be offered in the second trimester for women who did not have it earlier in pregnancy. NIPT offers higher sensitivity and specificity for common chromosomal conditions compared to the quad screen, though it is a screening test rather than a diagnostic one.
For women over 35 who did not complete first-trimester screening, second-trimester NIPT may be an option worth discussing with your OB/GYN. The appropriateness of NIPT — including what to do with various results — is a nuanced discussion that benefits from personalized guidance rather than a one-size-fits-all approach. Individual risk profiles, personal values, and plans for further testing all factor into the decision.
Diagnostic Testing: Amniocentesis
For women who receive concerning screening results or who prefer diagnostic certainty over probability-based screening, amniocentesis remains the gold standard for chromosomal diagnosis in the second trimester. Typically performed between 15 and 20 weeks, amniocentesis involves using a thin needle to collect a small amount of amniotic fluid, which contains fetal cells that can be analyzed for chromosomal and genetic conditions.
The procedure carries a small risk of pregnancy loss — current estimates from major medical centers put this risk at roughly 0.1 to 0.3 percent — though figures vary by provider experience and technique. The decision to pursue amniocentesis is deeply personal and involves weighing the information gained against the procedural risk. Many women find that consulting with a genetic counselor before making this decision is helpful, as counselors are trained specifically to discuss these trade-offs in a non-directive way.
Monitoring Maternal Health: Glucose and Other Tests
Beyond fetal assessments, the second trimester typically includes testing for gestational diabetes, which is more common in pregnancies after 35. The one-hour glucose challenge test is usually offered between 24 and 28 weeks and involves drinking a glucose solution and measuring blood sugar response one hour later. Women who screen positive are typically offered a three-hour diagnostic glucose tolerance test to confirm or rule out gestational diabetes.
Second-trimester blood work may also include a repeat complete blood count to check for anemia, which is common in pregnancy, as well as other assessments depending on your individual health history. If you have a condition such as hypertension, thyroid disease, or autoimmune issues, additional monitoring may be incorporated into your care. Staying engaged and informed throughout pregnancy after 35 or 40 involves being an active participant in these conversations rather than a passive recipient of testing.
Frequently Asked Questions
Are all second-trimester screenings mandatory after 35?
No — prenatal screenings are offered as options, not mandates. The decision to pursue any screening or diagnostic test is yours to make, ideally in consultation with your OB/GYN or a genetic counselor who can explain the benefits, limitations, and implications of each option. Individual values and circumstances vary considerably.
What happens if a screening test comes back abnormal?
An abnormal screening result typically leads to further evaluation, which might include additional imaging, repeat bloodwork, or an offer of diagnostic testing such as amniocentesis. An abnormal screen does not confirm a diagnosis — it identifies a pregnancy where closer evaluation may be warranted. Your provider should walk you through the next steps and options.
Is the anatomy ultrasound painful?
The anatomy scan is typically performed as a standard abdominal ultrasound and is not painful, though some women find extended lying in one position uncomfortable, particularly in later pregnancy. The scan can take 30–45 minutes or longer if the fetus is not in an optimal position for imaging.
Should I see a maternal-fetal medicine specialist?
Women over 35 are not automatically referred to maternal-fetal medicine (MFM) specialists — referral depends on your specific health history and pregnancy findings. However, if you have a pre-existing condition, receive an abnormal screening result, or simply want an additional expert perspective, asking your OB/GYN about an MFM consultation is a reasonable step.
Key Takeaways
- The second trimester offers a range of fetal and maternal screenings, each with distinct purposes, and none are mandatory — choices should be made in consultation with your provider.
- Screening tests estimate risk; they are not diagnoses, and an abnormal result requires further evaluation before drawing conclusions.
- The anatomy ultrasound is a comprehensive but imperfect assessment, and some conditions may not be detectable in this way.
- Gestational diabetes testing is typically offered between 24 and 28 weeks and is particularly relevant for women over 35.
- Genetic counselors can provide valuable non-directive guidance when decisions about diagnostic testing feel complex or uncertain.
Medical Disclaimer
This content is for informational purposes only and does not constitute medical advice. Individual health situations vary significantly. Always consult a qualified healthcare provider before making decisions related to your health, fertility, or pregnancy.
About the Author
Emily Carter is a women’s health writer focused on fertility, pregnancy after 35, and sleep changes in midlife. She writes research-informed, non-alarmist content to help women navigate reproductive and hormonal transitions with clarity and confidence.